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Cytochrome c oxidase (complex IV, CIV) is known in mammals to exist 
independently or in association with other respiratory proteins to form 
supercomplexes (SCs). In Saccharomyces cerevisiae, CIV is found solely in a 
SC with cytochrome bc1 (complex III, CIII). Here, we present the cryo-EM 
structure of S. cerevisiae CIV in a III2IV2 SC at 3.3 Å resolution. While overall 
similarity to mammalian homologues is high, we found notable differences in 
the supernumerary subunits Cox26 and Cox13; the latter exhibits a unique 
arrangement that precludes CIV dimerization as seen in bovine. A 
conformational shift in the matrix domain of Cox5A – involved in allosteric 
inhibition by ATP – may arise from its association with CIII. The CIII–CIV 
arrangement highlights a conserved interaction interface of CIII, albeit one 
occupied by complex I in mammalian respirasomes. We discuss our findings 
in the context of the potential impact of SC formation on CIV regulation.  
 
Introduction 
Cytochrome c oxidase (or complex IV, CIV) is the last enzyme in the mitochondrial 
electron transport chain whose activity drives oxidative phosphorylation, the process 
by which cells produce most of their ATP1. CIV is a complex multi-subunit protein 
embedded in the inner membrane of mitochondria. Its catalytic core, conserved 
across kingdoms, is composed of three subunits encoded in the mitochondrial DNA. 
CIV catalyses the reduction of molecular oxygen to water, conserving the released 
energy as coupled proton transfers across the membrane, through a mechanism that 
is still highly debated2. In addition, mitochondrial forms of CIV have supernumerary 
subunits (11 in humans), which are encoded in the nuclear genome. The 
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supernumerary subunits might have a role in CIV assembly or stability, or 
supercomplex (SC) formation, and there is an increasing interest in understanding 
the role of specific isoforms in optimising CIV core catalytic function in different 
tissues or physiological states3,4. 
CIV can exist as a monomer, a dimer, or in a SC with complexes I and/or III in 
varying stoichiometries (I–III2–IV1-4 and III2–IV1-2) with relative abundances 
depending on species5,6 and in mammals, tissue-type, cellular energy requirement 
and disease state7-10. Several structures of complex I-containing SCs have been 
published recently11-13 that provide details of their interaction. 
Despite its lack of complex I (CI), Saccharomyces cerevisiae has been 
extensively used as a model system for the study of mitochondrial respiratory chains, 
given its unique genetic amenability14. In the case of CIV, S. cerevisiae is the only 
system that contains the supernumerary subunits of so much interest (including 
isoforms), whilst allowing site-directed mutagenesis of the mitochondrial DNA. This 
uniquely permits the investigation of fundamental aspects of its catalytic mechanism 
as well as the identification of putative regulatory elements within supernumerary 
subunits. In addition, S. cerevisiae CIV is known to form SCs with cytochrome bc1
5 
(or complex III, CIII), so it represents an ideal opportunity to investigate the role of 
SC formation on CIV activity and regulation. 
High resolution structural information for the mitochondrial form of the enzyme 
is limited to crystal structures of dimeric bovine CIV2
15 and more recently a cryo-EM 
structure of human CIV16 within a respirasome. Here, we present the cryo-EM 
structure of S. cerevisiae CIV in a III2IV2 SC at 3.3 Å resolution. 
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Results 
Architecture of the III2IV2 SC. The III2IV2 SC was purified from S. cerevisiae 
mitochondrial membranes after solubilisation with glyco-diosgenin (GDN) and 
successive metal affinity and gel filtration chromatography (Supplementary Fig. 1). 
The purified SC is active and reduces molecular oxygen in the presence of 
exogenous cytochrome c at a rate of 30.4 ± 1.3 e.s-1 using decylubiquinol as a 
reductant. When no cytochrome c was added, no oxygen reduction was observed 
(Supplementary Fig. 1). 
The cryo-EM map (Table 1) reveals a CIII dimer at the core of the SC flanked 
by a CIV monomer on either side (Supplementary Fig. 2), as seen in previous low 
resolution models17,18. The core of the map was resolved to <3 Å, but the two CIV 
monomers could only be resolved to 5–8 Å, consistent with the dynamic nature of 
CIV within other SC structures11-13,19. To address this problem, we used subtracted 
experimental particle images, focusing only on masked refinements for each CIV 
monomer as previously described20. This procedure increased the resolution of the 
CIVa and CIVb monomers to 3.31 and 3.38 Å, respectively, revealing new atomic 
details (Supplementary Fig. 2 and Table 1). The improvement in resolution confirms 
that the two CIV monomers in the III2IV2 SC are identical. 
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Fig. 1 | Overall structure of the S. cerevisiae III2IV2 supercomplex. 
a, Side and top view of the III2IV2 supercomplex (SC) merged cryo-EM map with 
overall SC dimensions of 289x157x114 Å. CIII and CIV are represented in blue and 
orange, each monomer being represented by a different shade. The transparent grey 
density displays the extent of the GDN detergent belt. b, Side and top view of the 
III2IV2 SC model. CIII and CIV are represented in the same colours as in a, with 
Cox26 (green) and Qcr10 (red) highlighted. 
 
The merged map (Fig. 1) allowed us to build 44 protein subunits for the III2IV2 
SC, corresponding to all 20 protein subunits of the obligatory CIII dimer, including 
Qcr10, which is absent from all yeast structures published to date, and 12 protein 
subunits for  each CIV monomer; the 11 classically described subunits21,22 and the 
recently assigned Cox2623,24. The presence of all polypeptides forming the III2IV2 SC 
was confirmed by mass spectrometry analyses (Supplementary Table 1). Mass 
spectrometry also revealed the presence of the respiratory supercomplex factors 
Rcf1 and Rcf2 in the final protein preparation, but those proteins are absent from the 
cryo-EM structure. This observation supports the role of Rcf1 and Rcf2 in yeast SC 
formation25 but suggests that they are not essential for SC stability, which is similar 
to findings in mammalian systems. The high resolution of the map allowed the 
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confident modelling of 96% of all amino acids in the structure (Table 1). All prosthetic 
groups and metal cofactors are well defined, and 44 lipids including 8 cardiolipin 
molecules can be confidently modelled.  
 
Atomic resolution structure of the S. cerevisae CIV. The yeast CIV structure 
comprises 12 subunits (Fig. 2a, Supplementary Table 1). Cox1-3 form the catalytic 
core and are surrounded by 9 supernumerary subunits (Cox4-9, Cox12, Cox13, 
Cox26). The structure of yeast CIV is remarkably similar to mammalian systems, 
with a calculated RMSD against bovine26 and human16 enzymes of 0.95 and 1.10 Å, 
respectively, but there are notable differences as discussed below. Subunit 
composition is also very similar: all but one S. cerevisiae subunit (Cox26) have 
homologues in mammals and conversely, all mammalian subunits but three 
(COX7B, COX8 and NDUFA4) have yeast homologues. Yeast Cox5 (homologous to 
mammalian COX4) exists as one of two isoforms depending on oxygen level27. In 
normoxic conditions, almost all CIV is assembled with the Cox5A isoform, although 
low levels of Cox5B are also expressed. To enhance the homogeneity of our protein 
preparations, we used a COX5B knockout mutant strain (ΔCOX5B) that only 
expresses the Cox5A isoform. 
Cox1 and Cox2 house the prosthetic groups responsible for electron transfer 
and O2 reduction, namely the dinuclear CuA centre, haem a, haem a3 and CuB. All 
prosthetic groups are well resolved in the EM map, as well as the characteristic 
HPEVY ring of amino acids formed by covalent linkage between N2-His241 and C-
Tyr245 in Cox1 (Supplementary Fig. 3). Clear densities were observed at the 
expected magnesium and calcium/sodium binding sites in Cox1 (modelled as a Ca2+ 
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ion28) and the zinc binding site in Cox4. The density map also confirms the predicted 
positioning of the residues forming the D-, K- and H-channels described as putative 
proton pathways in Cox1 of A1-type oxidases29. 
 
Fig. 2 | Structure of S. cerevisiae CIV. 
a, Atomic model of CIV showing all 12 subunits. Cox1 is shown in yellow, Cox2 in 
cyan, Cox5A in pink, Cox26 in green, Cox9 in purple and Cox13 in orange. b, 
Interactions of Cox26 with Cox1, Cox2, Cox6, Cox9 (coloured as in a) and lipids 
(spacefill representation). c, Alignment of Cox5A (pink) with its bovine homologue 
(COX4-1 – grey and brown, PDB 1V54). The first ~50 amino acids are highlighted by 
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a darker shade. d, Differences in length and shape of the transmembrane helix of 
Cox13 with its bovine homologue (COX6A, PDB 1V54). 
 
Cox26, recently assigned as a subunit of S. cerevisiae CIV23,24, is composed of 
a single transmembrane helix with a kink towards its C-terminus. This arrangement 
enables extensive hydrophobic interactions with Cox1 and Cox2 (Fig. 2b), which are 
further supported by two lipids held against the core of the enzyme. In the matrix, 
Cox26 interacts at its N-terminus with Cox6 and Cox9 via a network of electrostatic 
and hydrophobic interactions (Fig. 2b). Deletion of Cox26 does not prevent CIV 
assembly, nor does it have any significant effect on its activity23,24. However, the 
position of Cox26 in the SC, and the interactions it makes with the subunits above, 
suggest Cox26 could stabilise the region of CIV at the interface with CIII, supporting 
a role in formation or stability of the III2IV2 SC, even though no direct connection with 
CIII is evident from the structure. 
A notable difference between yeast and mammalian CIV is the conformation of 
the N-terminal domain of Cox5A (Fig. 2c) which is shifted towards CIII in the S. 
cerevisiae SC to form protein-protein interactions further described below. This 
region is implicated in allosteric inhibition of CIV by ATP30-32 and Ser43, a residue 
which was shown by mutagenesis to contribute to this allosteric effect32, is at the 
interface with CIII. More detailed biochemical analyses will be required to determine 
whether SC formation has a role in the ATP feedback inhibition mechanism.  
Another difference is seen in Cox13, the most peripheral subunit of the SC (Fig. 
1c, Fig. 2a,d). Cox13 is characterised by a single extended and bow-shaped 
transmembrane -helix, protruding from the membrane into the matrix and the 
intermembrane space (IMS), with a  bulge between residues Ser55 and Leu60. The 
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N- and C- termini of Cox13 are oriented towards the core of the complex, interacting 
with Cox1 and Cox3 on the IMS and Cox4 on the matrix side. Its mammalian 
homologue, COX6A, has a shorter N-terminus that folds back into the membrane, 
providing the dimerization interface observed in the bovine crystal structure (Fig. 2d). 
The relevance of the dimeric state of CIV is still disputed, and refinement of CIV 
within the human respirasome16 showed that NDUFA4 would prevent dimerization 
via COX6A. Yeast does not have a NDUFA4 homologue but the peculiar 
arrangement of Cox13 observed here in the yeast SC would hinder CIV dimerization 
via this subunit. 
 
Complete structure of S. cerevisiae CIII. In S. cerevisiae, each CIII monomer 
consists of 10 subunits. Cytochrome b, cytochrome c1 and Rip1 form the catalytic 
core containing two haems B, one haem C and a [2Fe-2S] cluster, respectively. All 
prosthetic groups are visible in the density map along with a molecule of ubiquinone 
in two apparent configurations at the Qi site residing between the two cytochrome b 
subunits (Supplementary Fig. 4, Fig. 3). This is a common feature in structures of 
CIII of various origins, including yeast, whenever the hydrophobic substrate was not 
completely extracted from the preparation, and it is due to the higher affinity of 
ubiquinone to the Qi site as compared to Qo. Apart from the presence of Qcr10 and 
changes resulting from interactions with CIV (see below), our model is consistent 
with the CIII structures described previously33. 
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Fig. 3 | Interactions of Qcr10 with other subunits of CIII, and that of Rip1 with a 
lipid at the interface with CIV. 
a, Position of Qcr10 (pink ribbon) in the CIII structure with its N- and C-termini 
highlighted. Other subunits of CIII that interact with Qcr10 are highlighted in colours. 
A molecule of ubiquinone at the Qi site is shown as blue spheres. The boxes indicate 
specific regions of interaction that are highlighted in the other panels. b, Qcr10 (pink) 
forms interactions with the transmembrane helix of Rip1 (yellow) and with Qcr9 
(green) at both the matrix and IMS faces of the membrane. c, The N-terminal tail of 
Qcr10 interacts with Cor2 (purple) and Qcr7 (cyan) in the matrix. d, Interactions in 
the IMS between Qcr10 and Cytc1 (grey), Rip1 (yellow) and Qcr9 (green). e, A slight 
shift in the N-terminus of Rip1 (yellow) compared to the yeast X-ray structure (blue) 
accommodates interactions with a cardiolipin that goes on to interact with Cox5A of 
CIV (light pink), forming part of the interface between the two complexes. 
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Despite low sequence identity, the transmembrane helix of Qcr10 occupies a 
position similar to that of subunit 11 in mammalian structures34, making extensive 
interactions with Qcr9, and with Rip1 on the IMS side of the inner mitochondrial 
membrane (IMM) supported by a lipid (Fig. 3). In the matrix, the extended N-
terminus of Qcr10 interacts with Cor2, and Qcr7 of the other monomer, while in the 
IMS, Qcr10 extends to interact with cytochrome c1. These observations are in line 
with the proposed role of Qcr10 in CIII assembly and Rip1 stability35. 
A conformational change is observed at the N-terminus of the transmembrane 
helix of Rip1 due to interactions with a cardiolipin molecule that also interacts with 
Cox5A (Fig. 3 and below) suggesting SC formation could have a role in stabilising 
this part of CIII. However, this change at the N-terminus does not seem to impact the 
head domain of Rip1, which maintains its known flexibility. 
 
The CIII-CIV interface. Whilst the CIII dimer is symmetrical and no differences can 
be seen in the two CIII–CIV interfaces, the alignment of the two halves of the merged 
SC structure on CIII reveals a deviation of up to 3 Å at the extreme periphery of CIV 
(Supplementary Fig. 5). This most likely arises from the intrinsic flexibility of the SC 
and explains why a 3D refinement with C2 symmetry failed to improve the SC 
resolution (see Methods). 
The CIII–CIV interface reveals protein-protein interactions on either side of the 
IMM, and interactions via bridging lipids in the membrane region itself. The majority 
of interactions occur on the matrix side between Cor1 and the N-terminus of Cox5A, 
facilitated by the conformational shift in the latter as described above (Fig. 4a). In the 
IMS, the C-terminal domain of Cox5A is in position to interact with both the C-
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terminus of Qcr6 and a loop region between helices 6 and 7 of cytochrome c1 (Fig. 
4b-c). Within the membrane, Cox5A contacts the N-terminal helix of Rip1 and Qcr8 
via a cardiolipin molecule and another lipid modelled as phosphocholine (Fig. 4d). 
Two other cardiolipins indirectly support the CIII–CIV interface highlighting their 
crucial role in SC formation36. 
 
Fig. 4 | Protein-protein interactions between CIV and CIII.  
a and b, View from the matrix side of protein-protein interactions involving Cor1 
(white) and Cox5A (pink). Residues that make inter-subunit interactions are indicated 
and their interactions are shown as dashed lines. c, Interactions between 
cytochrome c1 (Cytc1, brown) and Qcr6 (pale green) with Cox5A (pink) in the IMS. d, 
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A cardiolipin molecule (CDL, yellow) and a phosphocholine (PCF, grey) within the 
membrane interacts with residues of Cox5A (pink), Rip1 (pale blue) and Qcr8 (blue). 
 
Previous work indicates that mammalian COX7A2L is required for the formation 
and stability of the CIII–CIV SC in mammals37 which is consistent with published 
respirasome structures11,12. S. cerevisiae has no homologue of COX7A2L so it must 
follow a different mechanism of CIII–CIV SC formation than the one proposed in 
mammals. In addition, our work suggests that the III2IV2 SC in yeast doesn’t require 
any other proteins to maintain its stability, the interaction between Cox5A and Cor1, 
two highly conserved subunits, and phospholipids being sufficient to stabilise the SC. 
However, no mammalian structure of the III2IV1/2 SC is currently available, and in the 
absence of CI, it cannot be excluded that the CIII–CIV interface is different in a 
III2IV1/2 supercomplex compared to the respirasome. Mammalian CIV has an 
additional subunit, COX7B, in front of COX4-1 (the mammalian homolog of Cox5A). 
However, superimposition of the bovine CIV structure onto the yeast III2IV2 SC 
suggests a similar interaction between CIII and CIV as the one observed in yeast 
remains possible (Supplementary Fig. 6). 
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Fig. 5 | Alignment of the mammalian I1III2IV1 respirasome with the III2IV2 SC 
from S. cerevisiae.  
a, The structures of the tight ovine I1III2IV1 respirasome
11 (PDB 5J4Z, displayed in 
shades of grey) and the yeast III2IV2 SC (coloured as in Figure 1). b, These 
structures were aligned on their CIII dimers. The view in both a and b is from the 
IMS. 
 
 
Discussion 
The functional role of SC formation is still unclear38,39. Reactive oxygen species 
(ROS) prevention by steric inhibition of one half of CIII by CIV in the respirasome has 
been proposed40. In the yeast III2IV2 SC, the symmetry of CIII is maintained and no 
obvious interactions are apparent that could stabilise the hinge region of Rip1, 
whose flexibility allows the movement of the head group domain, which is implicated 
in ROS production. However, it is noteworthy that the same subunits of CIII are 
involved in SC formation in all SC structures resolved so far (Fig. 5). The 
homologues of yeast CIII subunits Cor1, Rip1, Qcr6 and Qcr8 interact with CI in the 
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mammalian respirasome structures. These are the same subunits that interact with 
CIV in our III2IV2 structure, highlighting a conservation of the CIII interaction 
interface, albeit one occupied by CI in mammals and by CIV in S. cerevisiae, which 
lacks CI. Additionally, in the CI-containing Y. lipolytica respirasome, where the CIII 
symmetry is apparently maintained, the suggested CIII–CIV arrangement is similar to 
the one observed in the yeast III2IV2 SC
6. This suggests that SC formation may 
serve to stabilise the active CIII monomer(s) by other proteins.  
Finally, modulation of CIV activity in response to energy requirements by 
differential expression of isoforms such as Cox5 in yeast41 (COX4 in mammals4) and 
COX7A in mammals42 has been recognised. From the yeast structure presented 
here, and that of mammalian respirasomes, it seems that these subunits form a 
substantial part of the interface between proteins in SCs. Therefore, biochemical and 
biophysical studies investigating these isoforms, and the effect of allosteric sites 
identified within supernumerary subunits on CIV core catalytic subunits, must take 
into account SC formation. With homologues of many mammalian supernumerary 
subunits, extensive genetic amenability and in light of the SC structures now 
available, S. cerevisiae offers a powerful system to study how these factors 
modulate CIV activity and respiratory SC formation. 
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Tables 
Table 1 | Cryo-EM data collection, refinement and validation statistics 
 III2IV2 SC 
(EMD-0262, 
 PDB 6HU9) 
CIVa 
(EMD-0269) 
CIVb 
(EMD-0268) 
Data collection and 
processing 
   
Magnification 130,000   
Voltage (kV) 300   
Electron exposure (e
–
/Å
2
) 1.645   
Defocus range (μm) -1.6 to -3.6     
Pixel size (Å) 1.048   
Symmetry imposed C1   
Initial particle images (no.) 98,968   
Final particle images (no.) 44,915   
Map resolution (Å) 3.31 3.31 3.38 
    FSC threshold 0.143 0.143 0.143 
Map resolution range (Å) - - - 
Map sharpening B factor (Å
2
) -60.26 -69.04 -79.03 
    
Refinement
1
    
Initial model used (PDB code) 1KYO, 1V54   
Model resolution (Å)
2
 3.35   
    FSC threshold 0.50   
Model resolution range (Å) 3.35   
Model composition    
    Nonhydrogen atoms 63,033    
    Protein residues 7,636   
    Ligands 69   
B factors (Å
2
)
3
    
    Protein 59.9 (141.4 – 20.7)   
    Ligand 54.9 (149.7 – 35.5)   
R.m.s. deviations    
    Bond lengths (Å) 0.01    
    Bond angles (°) 1.32    
    
Validation
3
    
MolProbity score 2.32   
Clashscore 5.62    
Poor rotamers (%) 8.49    
Ramachandran plot    
    Favored (%) 95.61   
    Allowed (%) 4.35   
    Disallowed (%) 0.04   
1.
 The model was refined against a map generated by merging the map from the 3D refinement (III2IV2 SC) with 
the two maps generated after particle subtraction and 3D refinement focused on CIVa or CIVb.  
2.
 Determined by phenix.mtriage 
3.
 Determined by phenix.molprobity (values in parenthesis denote highest and lowest values) 
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Methods 
Yeast strain and cell growth. A ΔCOX5B S. cerevisiae strain only expressing the 
Cox5A isoform of CIV ( ade2 leu2 trp1 ura3 cox5B::KanMx4) with a six-histidine-tag 
at the C-terminus of COX13 was constructed from W303-1B43,44. Yeast cells were 
grown in YPGal (1% yeast extract, 2% peptone and 2% galactose) medium at 28˚C 
in 2 L baffled flasks with shaking at 200 rpm as described in Meunier et al.43. Cells 
were harvested in late log phase by centrifugation at 6500 rpm for 5 minutes at 4˚C. 
Cells were washed by resuspension in 50 mM KPi, pH 7.0, and centrifuged again. 
Cell pellets were stored at -80˚C until use. 
Preparation of mitochondrial membranes. Mitochondrial membranes were 
prepared essentially as described previously43. Briefly, thawed yeast cells were 
resuspended in 30 mL 650 mM D-mannitol, 50 mM KPi, 5 mM EDTA, pH 7.4 
containing 0.1 mM PMSF. Glass beads (425-600 μm diameter) were added and cells 
were broken by mechanical lysis using a bead-beater cell disruptor. Cell debris was 
removed by centrifugation at 5600 × g for 20 minutes at 4˚C, and the supernatant 
was centrifuged at 120,000 × g for 50 minutes at 4˚C to harvest the mitochondrial 
membranes. The membranes were then resuspended and homogenised in 50 mM 
KPi, 100 mM KCl, 10 mM MgCl2, 150 μM CaCl2, 0.1 mM PMSF, pH 7.4, and 
centrifuged as in the previous step. The pellet was then washed by cycles of 
resuspension/centrifugation in 50 mM KPi, 2 mM EDTA, 0.1 mM PMSF, pH 7.4, until 
the measure of the absorbance of the supernatant at 260 nm was below 1. Finally, 
the membranes were resuspended in a minimal volume of 50 mM HEPES, pH 8.0, 
and stored at -80˚C until use. 
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Membrane solubilisation and SC purification. Membranes were diluted in 50 mM 
HEPES, 150 mM NaCl, 1 mM PMSF, pH 8.0 to a CIII concentration of 45 nM and 
protein complexes were solubilised for 1 hour on ice by the addition of 1% GDN 
(glyco-diosgenin, Anatrace). After solubilisation, 350 mM NaCl (to make 500 mM 
final) and 5 mM imidazole are added. Insoluble material was removed by 
centrifugation at 120,000 × g for 30 minutes at 4˚C. Solubilised proteins were then 
loaded overnight in a cold room at a flow rate of approx. 0.6 mL/min using a 
peristaltic pump onto a 5 mL HisTrap HP column (GE Healthcare) previously 
equilibrated with 2 column volumes (CV) of 50 mM HEPES, 500 mM NaCl, 5 mM 
imidazole, 0.05% GDN, pH 8.0. After loading, the column was washed with 3 CV of 
50 mM HEPES, 500 mM NaCl, 5 mM imidazole, 0.05% GDN, pH 8.0, and then with 
5 CV of 50 mM HEPES, 150 mM NaCl, 0.05% GDN, 5 mM imidazole, pH 7.2. Bound 
proteins were eluted with 50 mM HEPES, 150 mM NaCl, 0.05% GDN, 100 mM 
imidazole, pH 7.2. The eluted proteins were concentrated by centrifugation using 100 
kDa MWCO centrifugal concentrators (GE Healthcare). The resulting sample was 
then further purified by gel filtration, using an Äkta Pure 25 (GE Healthcare) operated 
at 4˚C with UV detection at 280 nm and automated fraction collection, by loading on 
a Superose 6 Increase column (GE Healthcare) equilibrated with 50 mM HEPES, 
150 mM KCl, 0.05% GDN, pH 7.2. Fractions containing SCs were pooled and 
concentrated as above, and reapplied once to the same column. 
Analytical methods. Resulting fractions were then concentrated and analysed for 
haem content and purity using UV-visible difference spectroscopy and BN-PAGE. 
Final protein concentration was determined by the Pierce BCA protein assay 
(Thermo Scientific) as per the manufacturer’s protocol. 
22 
 
UV-visible difference spectroscopy. UV-visible difference spectra were 
recorded between 400 and 700 nm using a home built spectrophotometer. Protein 
samples were diluted as necessary in 50 mM HEPES, 0.1% UDM, pH 8.0. Spectra 
were measured from sodium dithionite reduced minus oxidised spectra, using 
absorption coefficients (ΔƐ) of 26 mM
-1 cm-1 (604-621 nm) and 28 mM-1 cm-1 (562-
578 nm) for CIV and CIII respectively. 
Gel electrophoresis. Protein samples for BN-PAGE analysis were mixed with 
BN-PAGE sample buffer (final concentration, 50 mM BisTris, 50 mM NaCl, 10% 
(w/v) glycerol, 0.001% Ponceau S, pH 7.2) as per the manufacturer’s instruction 
(Invitrogen). Pre-cast 3-12% BisTris gels (Novex) were used throughout, and run at 
150 V for 90-120 minutes. The running buffer contained 50 mM BisTris, 50 mM 
Tricine, pH 6.8, and the cathode buffer was made by addition of 0.002% Coomassie 
G-250 to the running buffer. Gels were destained overnight using 10% (v/v) acetic 
acid, followed by multiple exchanges of water. 
Mass spectroscopy. 50 µg protein of purified III2IV2 SC sample were diluted 1:4 in 
reducing sample buffer consisting of 12% (w/v) SDS, 6% (v/v) β-mercaptoethanol, 
30% (w/v) glycerol, 0.05% Coomassie blue G-250 (Serva), 150 mM Tris-HCl pH 7.0 
and incubated for 15 min at 37°C. Samples were loaded onto a 10% Tricine-SDS 
polyacrylamide gel and the electrophoresis was performed according to Schägger45 
until the entire amount of protein entered into the gel (~30 min; 50 V). A molecular 
mass marker (Precision plus protein standards, dual colour, BioRad) was used to 
monitor the correct loading of proteins into the gel. Gel-spots containing SC III2IV2 
were cut and prepared for MS identification, following the in-gel trypsin digestion 
protocol described previously46. Tryptic peptides were separated by liquid 
chromatography and analysed by tandem mass spectrometry (LC-MS/MS) in a Q-
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Exactive 2.0 Orbitrap Mass Spectrometer equipped with an Easy nLC1000 nano-flow 
ultra-high pressure liquid chromatography system (Thermo Fisher Scientific). MS 
was run twice for each sample. MS raw data files were analysed using the 
MaxQuant software (v1.5.0.25) using the settings detailed in Guerrero-Castillo et 
al.47, except for the search against a compiled version of the S. cerevisiae protein 
database including the pig trypsin and other protein contaminants, such as human 
keratins.  
Activity measurements. Steady-state oxygen consumption rates were measured 
using a Clark-type oxygen electrode (Oxygraph, Hansatech), operated at 25˚C. 
Assays were conducted with purified protein at 15 nM, in 10 mM KPi, 50 mM KCl, pH 
6.6, supplemented with 0.05% GDN, 500 units/mL SOD and 250 units/mL catalase. 
SC activity was measured in the presence and absence of 50 μM equine heart 
cytochrome c. The reaction was initiated by addition of 40 μM decylubiquinol. The 
reaction was stopped by addition of 1 mM KCN and the resulting rate was used as a 
baseline. Turnover numbers were calculated from linear fitting of the oxygen 
consumption rate using Origin (OriginLab, Northampton, MA) following the formula 
T.N. (e s-1) = O2 consumption gradient (M.s
-1) x 4 / [CcO] (M). The result presented is 
the average of four independent experiments (± standard deviation) from two 
independent protein preparations for cryo-EM. 
Cryo-electron microscopy. Purified III2IV2 SC (9 mg/mL total protein) was diluted 
1:3 in 50 mM HEPES, 150 mM NaCl, 0.05 % GDN, pH 7.2 and applied to glow 
discharged UltrAuFoil R1.2/1.3 grids (Quantifoil). Grids were blotted for 8.5 seconds 
at 4˚C and 100% humidity, and then rapidly frozen in liquid ethane using a Vitrobot 
Mark IV (Thermo Fisher) and stored in liquid nitrogen. Preliminary imaging was done 
using a Polara microscope operated at 300 kV and equipped with a Quantum energy 
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filter (Gatan) with a post-GIF K2 Summit direct electron detector (Gatan) operating in 
counting mode. The primary data were collected using a Titan Krios microscope 
(Thermo Fisher) operated at 300 kV and equipped with a Quantum energy filter 
(Gatan) (electron Bio-Imaging Centre, Diamond Light Source, Oxfordshire, UK). The 
images were collected with a post-GIF K2 Summit direct electron detector (Gatan) 
operating in counting mode at a nominal magnification of 130,000x, corresponding to 
the pixel size of 1.048 Å. An energy slit with a width of 20 eV was used during data 
collection. The dose rate on the specimen was set to 6.58 electrons per Å2 per s and 
a total dose of 52.64 e/Å2 was fractionated over 32 frames. Data were collected 
using EPU software (Thermo Fisher) with a nominal defocus range set from -1.6 μm 
to -3.6 μm. A total of 2740 micrographs were collected. 
Image processing. Frame alignment and exposure weighting were performed with 
MOTIONCOR248. Contrast transfer function parameters of the motion-corrected 
micrographs were estimated with CTFFIND4.149. Micrographs were screened 
manually to remove those with excessive specimen drift, overfocus or ice defects. 
98,968 particles were selected from the 2634 remaining micrographs using 
reference-free particle picking with Gautomatch v0.53 (written by Dr Kai Zhang, 
https://www.mrc-lmb.cam.ac.uk/kzhang/Gautomatch/), using a 360×360 Å2 box size. 
Particles were sorted using several iterations of reference-free 2D classification in 
cryoSPARC50, resulting in a final particle number of 52,257. An initial model was 
build using ab-initio reconstruction in cryoSPARC, which was refined using 
heterogeneous refinement in RELION v3.051. The III2IV2 SC accounted for 44,915 
(86%) of the particles present (14% represented the III2IV1 supercomplex), and these 
particles were then used for homogeneous refinement in RELION v3.0 resulting in a 
3.31 Å resolution map, based on the FSC-gold standard. Local resolution was 
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calculated using ResMap52, revealing a range of resolutions in the map, with the core 
of CIII resolved to 2.9-3.2 Å, whereas the peripheral edges of the two CIV proteins 
were resolved to 5-8 Å. 
To increase the resolution of the two CIV monomers, we used a particle 
subtraction approach20. In short, a soft mask was generated around III2IVb and used 
to subtract density from the particles, resulting in a new set of particles which was 
used for focussed 3D refinement of CIVa. This process was repeated with a soft 
mask around III2IVa to refine CIVb. This resulted in an increased resolution of the two 
CIV monomers to 3.31 Å and 3.38 Å, with a homogeneous distribution of resolution 
throughout the protein (Supplementary Fig. 2). The two CIV maps were then aligned 
to the original map of the SC and a merged map was generated using UCSF 
Chimera53.  
Model building. The three individual maps described above were used for all 
model building using real space refinement (Table 1) in Coot54. A high resolution 
crystal structure of dimeric CIII (PDB 1KYO)55, and a yeast homology model22 were 
used as starting references for model building. All maps displayed clearly 
interpretable features such as bulky side chains, metal clusters, haem ligands, 
cardiolipin and ubiquinone. These features enabled unambiguous assignment of 
amino-acids in all chains, except some flexible N- and C-termini. Notably, the C-
terminus of Rip1 of CIII has weak density (residues 95-215), and this is attributed to 
its characteristic flexibility. Its Fe-S cluster is clearly visible in the map. Finally, the N-
terminal residues of Qcr6 (1-73) in CIII, are not resolved, a feature common to all 
yeast CIII crystal structures, possibly due to the high composition of charged 
residues in this region. Additional densities in the map indicated the presence of long 
carbon chains which were modelled as di-palmitoyl-phosphatidylethanolamine 
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(PEF), diacyl-glycero-phosphocholine (PCF) and cardiolipin (CDL) molecules based 
on map interpretation and similarities with previous structures where these ligands 
were found. Lipid tails were truncated according to the density maps. The three 
models (dimeric CIII, and two CIV monomers) where then individually refined using 
the real space refine tool in Phenix56, using secondary structure restraints. Geometry 
definitions for the ligands were defined from values in the CCP4 ligand library57. 
Additional bond and distance restraints were implemented on specific molecules 
based on previously published high resolution structures. For initial refinement in 
Phenix, Ramachandran and rotamer constraints were also used. The models were 
then visually inspected in Coot for additional corrections. A final real space 
refinement was performed in Phenix by disabling rotamer constrains resulting in an 
increase of the model-to-map fit. To confirm the validity of the map, a final real space 
refinement was performed to the complete III2IV2 SC using the merged map 
described above. The final model contains 7,636 protein residues and 69 ligands. 
For the CIII dimer we modelled four B-haems and one ubiquinone molecule in the 
two cytochrome b subunits, one C-haem for each cytochrome c1 subunit, one [2Fe-
2S] iron-sulphur cluster for each Rip1 subunit, eight cardiolipin molecules, twelve 
PEF and six PCF molecules. For each CIV we modelled a haem a, haem a3 and CuB 
in Cox1 as well as one calcium and one magnesium ions. In Cox2 we modelled a 
dinuclear CuA centre and in Cox4 one zinc ion. Each CIV contains additionally eight 
PEF molecules and one PCF molecule. Refinement and model statistics are 
summarized in Table 1. Map and molecule representations in the figures were 
prepared by PyMOL (https://pymol.org/) and UCSF Chimera.  
 
Data availability 
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All relevant data are included in the manuscript and/or are available from the 
corresponding authors upon reasonable request. Cryo-EM maps have been 
deposited in the Electron Microscopy Data Bank (EMDB) under accession codes 
EMD-0262 (III2IV2 SC), EMD-0269 (CIVa), EMD-0268 (CIVb). The coordinates of the 
atomic model of the III2IV2 SC built from a combination of the three maps have been 
deposited in the Protein Data Bank (PDB) under accession code 6HU9. 
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Supplementary Figure 1. Biochemical characterisation of S. cerevisiae III2IV2 SC. 
a, UV-visible redox spectrum of the purified yeast III2IV2 SC. Peaks are labelled and correspond to the 
A-type haems present in CIV (445/604 nm) and the B- and C-type haems present in CIII (432/562 nm 
and 554 nm). b, Gel filtration profile of the yeast III2IV2 SC. The fraction eluting between 12-12.5 mL 
was used for cryo-EM. c, BN-PAGE gel of the purified yeast III2IV2 SC. d, Oxygen consumption rate of 
the III2IV2 SC (red line) in the presence of 50 M cytochrome c, initiated by addition of 40 M 
decylubiquinol (decylUQH2). A baseline (green) is recorded after addition of 1 mM KCN, an inhibitor 
of CIV. e, Oxygen consumption rate of the III2IV2 SC without exogenous cytochrome c (experiment 
details are as in d). Data in a-c are representative of three independent experiments with similar 
results. 
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Supplementary Figure 2. Cryo-EM data collection and workflow of 3D classification and 
focussed refinement. 
a, A representative cryo-EM micrograph of III2IV2 SC (scale bar, 30 nm). b, Representative 2D class 
averages of the III2IV2 SC (scale bar, 20 nm). c, Fourier shell correlation (FSC) curves between two 
independently refined half-maps for the III2IV2 SC map, and for the two CIV maps, each individually 
refined. d, Surface rendering maps coloured according to local resolution. Upper and middle present 
the maps of the III2IV2 SC, and CIVa and CIVb after focused refinement. The lower display shows the 
central sections of the two CIV maps to emphasise further the improvement in resolution (scale bar, 
50 Å). e, Euler angle distributions of the 44,915 particles included in the calculation of the III2IV2 SC 
map for two orientations rotated by 90 degrees. Data collection and structure calculation were not 
repeated. 
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Supplementary Table 2. Mass spectrometry analysis of the subunits present in the yeast 
III2IV2 SC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Gene name Protein name 
Uniprot 
entry 
Precursor 
Mr 
Mature 
Mr 
Mature 
protein 
Peptides 
identified
 
Sequence 
coverage
 
IBAQ 
value 
 
  kDa kDa residues total unique % x10
6 
Cytochrome c oxidase         
COX1 Cox1 P00401 58.797 58.797 1-534 5 5 13.9 200 
COX2 Cox2 P00410 28.567 26.763 16-251 10 10 53.0 2,368 
COX3 Cox3 P00420 30.360 30.360 1-269 1 1 6.3 59 
COX4 Cox4 P04037 17.143 14.172 26-155 13 13 85.8 2,017 
COX5A Cox5A P00424 17.140 14.875 21-153 11 9 42.5 805 
COX6 Cox6 P00427 17.341 12.627 41-148 9 9 54.7 1,319 
COX7 Cox7 P10174 6.932 6.801 2-60 2 2 20.0 505 
COX8 Cox8 P04039 8.907 5.366 28-74 1 1 12.8 261 
COX9 Cox9 P07255 6.963 6.461 2-56 7 7 39.0 2,220 
COX12 Cox12 Q01519 9.788 9.657 2-83 8 8 81.9 271 
COX13 Cox13 P32799 15.021 13.837 10-129 11 11 68.2 651 
COX26 Cox26 Q2V2P9 7.452 7.452 1-66 3 3 30.3 1,008 
RCF1 Rcf1, AIM31 Q03713 18.477 18.477 1-159 18 18 79.2 352 
RCF2 Rcf2, AIM38 P53721 25.344 25.344 1-224 12 12 45.1 921 
          
Cytochrome bc1 complex         
COB cytochrome b P00163 43.656 43.656 1-385 3 3 7.0 1,211 
CYT1 
cytochrome 
c1 
P07143 34.055 27.771 62-309 18 18 59.5 2,995 
RIP1 Rip1 P08067 23.365 20.099 31-215 19 19 60.9 2,742 
COR1 Cor1 P07256 50.227 47.409 27-457 33 33 76.4 4,107 
QCR2 Cor2 P07257 40.478 38.705 17-368 40 40 85.6 4,039 
QCR6 Qcr6 P00127 17.257 17.257 1-147 4 4 32.0 1,023 
QCR7 Qcr7 P00128 14.565 14.565 1-127 13 13 90.6 3,052 
QCR8 Qcr8 P08525 10.974 10.974 1-94 7 7 68.1 1,202 
QCR9 Qcr9 P22289 7.476 7.345 2-66 3 3 28.8 1,642 
QCR10 Qcr10 P37299 8.593 8.462 2-77 5 5 46.8 587 
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Supplementary Figure 3. Fitting of the CIV model into the cryo-EM density. 
a, Fitting of co-factors, metal clusters and identified lipids into the CIVa cryo-EM map density. Below 
each model are the names of the co-factor/metal/lipid, alongside the domain, and chain as in PDB 
6HU9, they belong to. The numbering refers to residues found nearby, or providing coordination 
(PEF, palmitoyl-phosphatidylethanolamine, PCF, diacyl-glycero-phosphocholine). b, Two examples of 
high resolution α-helical regions of CIV, Cox5A which forms the interface with CIII, and the core 
domain Cox1. c, Fitting of a -sheet from Cox2. d, Fitting of the distal subunit Cox13 (chain k) and the 
new subunit Cox26 (chain l) into the density. The N- and C-termini of the chains are indicated. The 
corresponding co-factors, metals, lipids and subunits from the other CIV monomer (CIVb) display 
identical density (not shown). 
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Supplementary Figure 4. Fitting of the CIII model into the cryo-EM density. 
a, Fitting of co-factors, metal clusters and identified lipids into the III2IV2 SC cryo-EM map density. 
Below each model are the names of the co-factor/metal/lipid, alongside the domain, and chain as in 
PDB 6HU9, they belong to. The numbering refers to residues found nearby, or providing 
coordination (PEF, palmitoyl-phosphatidylethanolamine, PCF, diacyl-glycero-phosphocholine). b, 
Fitting of the subunits Rip1 (chain E) and Qcr10 (chain J) into the density. The N- and C-termini of the 
chains are indicated. Note the lower resolution of the flexible C-terminal catalytic domain of Rip1 
(zoom in). This domain, as well as Qcr10, display higher B-factors compared to the other subunits of 
CIII (not shown). The corresponding domains from the second monomer of CIII display identical 
density (not shown). 
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Supplementary Figure 5. Structural alignment of the two halves of the III2IV2 SC. 
a, Side and b, top views of a structural alignment of the two halves of the III2IV2 SC, aligned on their 
core CIII subunits, Cor1, Cor2 and cytochrome b. This reveals minimal deviation of Cox5A at the SC 
interface (~0.3-0.5 Å), but a larger deviation of Cox13 (3.0 Å), at the extreme periphery of the SC. 
Cox26 and Qcr10 are displayed in green and red, respectively. 
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Supplementary Figure 6. Position of COX7B would not preclude interactions via COX4-1 in a 
mammalian CIII-CIV SC. 
a, Side and b, top view of a putative mammalian III2IV1 SC formed after substitution of the yeast CIV 
monomer (CIVa) with bovine CIV (PDB 1V54) as per our III2IV2 SC structure (the other CIV is not 
shown). COX7B (blue), a subunit of mammalian CIV lies near COX4-1 (pale cyan; the homologue of 
yeast Cox5A). However, it would not interfere with any interactions between CIII and COX4-1, such 
as those seen in the yeast III2IV2 SC structure. COX7A (deep red), the subunit involved in interactions 
with CIII in the mammalian I1III2IV1 respirasome is also highlighted. 
 
